Intravenous palonosetron increases the incidence of QTc prolongation during sevoflurane general anesthesia for laparotomy

BackgroundPalonosetron is a recently introduced 5-hydroxytryptamine-3 (5-HT3) receptor antagonist useful for postoperative nausea and vomiting prophylaxis. However, 5-HT3 receptor antagonists increase the corrected QT (QTc) interval in patients who undergo general anesthesia. This retrospective stud...

Full description

Bibliographic Details
Main Authors: Jeong Jin Min, Yongjae Yoo, Tae Kyong Kim, Jung-Man Lee
Format: Article
Language:English
Published: Korean Society of Anesthesiologists 2013-11-01
Series:Korean Journal of Anesthesiology
Subjects:
Online Access:http://ekja.org/upload/pdf/kjae-65-397.pdf
id doaj-c962c76b06694000bb389ac6b87e3c7b
record_format Article
spelling doaj-c962c76b06694000bb389ac6b87e3c7b2020-11-25T01:43:13ZengKorean Society of AnesthesiologistsKorean Journal of Anesthesiology2005-64192005-75632013-11-0165539740210.4097/kjae.2013.65.5.3977689Intravenous palonosetron increases the incidence of QTc prolongation during sevoflurane general anesthesia for laparotomyJeong Jin Min0Yongjae Yoo1Tae Kyong Kim2Jung-Man Lee3Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.BackgroundPalonosetron is a recently introduced 5-hydroxytryptamine-3 (5-HT3) receptor antagonist useful for postoperative nausea and vomiting prophylaxis. However, 5-HT3 receptor antagonists increase the corrected QT (QTc) interval in patients who undergo general anesthesia. This retrospective study was performed to evaluate whether palonosetron would induce a QTc prolongation in patients undergoing general anesthesia with sevoflurane.MethodsWe reviewed a database of 81 patients who underwent general anesthesia with sevoflurane. We divided the records into palonosetron (n = 41) and control (n = 40) groups according to the use of intraoperative palonosetron, and analyzed the electrocardiographic data before anesthesia and 30, 60, 90, and 120 min after skin incision. Changes in the QTc interval from baseline, mean blood pressure, heart rate, body temperature, and sevoflurane concentrations at each time point were compared between the two groups.ResultsThe QTc intervals at skin incision, and 30, 60, 90, and 120 min after the skin incision during general anesthesia were significantly longer than those at baseline in the two groups (P < 0.001). The changes in the QTc intervals were not different between the two groups (P = 0.41). However, six patients in the palonosetron group showed a QTc interval > 500 ms 30 min after skin incision, whereas no patient did in the control group (P = 0.01). No significant differences were observed between the two groups in mean blood pressure, body temperature, heart rate, or sevoflurane concentrations.ConclusionsPalonosetron may induce QTc prolongation during the early general anesthesia period with sevoflurane.http://ekja.org/upload/pdf/kjae-65-397.pdfcardiac arrhythmiaelectrocardiographygeneral anesthesiapalonosetronpatient safetysevoflurane
collection DOAJ
language English
format Article
sources DOAJ
author Jeong Jin Min
Yongjae Yoo
Tae Kyong Kim
Jung-Man Lee
spellingShingle Jeong Jin Min
Yongjae Yoo
Tae Kyong Kim
Jung-Man Lee
Intravenous palonosetron increases the incidence of QTc prolongation during sevoflurane general anesthesia for laparotomy
Korean Journal of Anesthesiology
cardiac arrhythmia
electrocardiography
general anesthesia
palonosetron
patient safety
sevoflurane
author_facet Jeong Jin Min
Yongjae Yoo
Tae Kyong Kim
Jung-Man Lee
author_sort Jeong Jin Min
title Intravenous palonosetron increases the incidence of QTc prolongation during sevoflurane general anesthesia for laparotomy
title_short Intravenous palonosetron increases the incidence of QTc prolongation during sevoflurane general anesthesia for laparotomy
title_full Intravenous palonosetron increases the incidence of QTc prolongation during sevoflurane general anesthesia for laparotomy
title_fullStr Intravenous palonosetron increases the incidence of QTc prolongation during sevoflurane general anesthesia for laparotomy
title_full_unstemmed Intravenous palonosetron increases the incidence of QTc prolongation during sevoflurane general anesthesia for laparotomy
title_sort intravenous palonosetron increases the incidence of qtc prolongation during sevoflurane general anesthesia for laparotomy
publisher Korean Society of Anesthesiologists
series Korean Journal of Anesthesiology
issn 2005-6419
2005-7563
publishDate 2013-11-01
description BackgroundPalonosetron is a recently introduced 5-hydroxytryptamine-3 (5-HT3) receptor antagonist useful for postoperative nausea and vomiting prophylaxis. However, 5-HT3 receptor antagonists increase the corrected QT (QTc) interval in patients who undergo general anesthesia. This retrospective study was performed to evaluate whether palonosetron would induce a QTc prolongation in patients undergoing general anesthesia with sevoflurane.MethodsWe reviewed a database of 81 patients who underwent general anesthesia with sevoflurane. We divided the records into palonosetron (n = 41) and control (n = 40) groups according to the use of intraoperative palonosetron, and analyzed the electrocardiographic data before anesthesia and 30, 60, 90, and 120 min after skin incision. Changes in the QTc interval from baseline, mean blood pressure, heart rate, body temperature, and sevoflurane concentrations at each time point were compared between the two groups.ResultsThe QTc intervals at skin incision, and 30, 60, 90, and 120 min after the skin incision during general anesthesia were significantly longer than those at baseline in the two groups (P < 0.001). The changes in the QTc intervals were not different between the two groups (P = 0.41). However, six patients in the palonosetron group showed a QTc interval > 500 ms 30 min after skin incision, whereas no patient did in the control group (P = 0.01). No significant differences were observed between the two groups in mean blood pressure, body temperature, heart rate, or sevoflurane concentrations.ConclusionsPalonosetron may induce QTc prolongation during the early general anesthesia period with sevoflurane.
topic cardiac arrhythmia
electrocardiography
general anesthesia
palonosetron
patient safety
sevoflurane
url http://ekja.org/upload/pdf/kjae-65-397.pdf
work_keys_str_mv AT jeongjinmin intravenouspalonosetronincreasestheincidenceofqtcprolongationduringsevofluranegeneralanesthesiaforlaparotomy
AT yongjaeyoo intravenouspalonosetronincreasestheincidenceofqtcprolongationduringsevofluranegeneralanesthesiaforlaparotomy
AT taekyongkim intravenouspalonosetronincreasestheincidenceofqtcprolongationduringsevofluranegeneralanesthesiaforlaparotomy
AT jungmanlee intravenouspalonosetronincreasestheincidenceofqtcprolongationduringsevofluranegeneralanesthesiaforlaparotomy
_version_ 1725032732756541440